|
| Status |
Public on Dec 31, 2021 |
| Title |
Biopsy 2 |
| Sample type |
genomic |
| |
|
| Source name |
FFPE GBM Primary tumor sample, Trial arm: Treatment
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: glioblastoma tumor
subject: Subject_2
primary_recurrence: Primary
slide: 401939640302/2
array: R03C01
ChIP: 742293
age (years): 59
Sex: M
vital status: Dead
overall survival (days): 693
treatment time (days): 279
trial arm: Treatment
estimated sample purity: 0.921800223
fresh frozen (ff) or ffpe: FFPE
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
genomic DNA was extracted and purified from samples using Qiagen DNeasy Kit according to standard instructions
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium HumanMethylationEPIC Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
| Description |
200969820151_R03C01
|
| Data processing |
BeadStudio software
|
| |
|
| Submission date |
Mar 09, 2018 |
| Last update date |
Dec 31, 2021 |
| Contact name |
Lucas A. Salas |
| E-mail(s) |
[email protected]
|
| Organization name |
Geisel School of Medicine at Dartmouth
|
| Department |
Epidemiology
|
| Lab |
Salas Lab
|
| Street address |
1 Medical Center Dr, DHMC
|
| City |
Lebanon |
| State/province |
NH |
| ZIP/Postal code |
03756 |
| Country |
USA |
| |
|
| Platform ID |
GPL21145 |
| Series (1) |
| GSE111627 |
DNA methylome evolution and reprogramming in recurrent glioblastoma |
|
